Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The KEO Trial
NCT03325465Phase 2Withdrawn
- Sponsor
- University of Chicago
- Start
- Jan 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in squamous cell carcinoma of the head and neck (HNSCC), sponsored by University of Chicago. Planned start Jan 2018; status: withdrawn.
02
Drugs
epacadostat
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03325465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03325465.